Results

Total Results: 289 records

Showing results for "sedation".

61. Depression Treatment after Unsatisfactory Response to SSRIs when used as First-line Therapy | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/depression-treatment-ssri/research-protocol
    December 01, 2019 - Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation

62. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
    September 03, 2019 - review SPECIFICALLY involves antipsychotics for delirium, and NOT for other potential uses such as sedation … Public Reviewer #1 (Medicus, Jennifer [APA]) Results Page 29, sedation haloperidol v placebo – in … The absence of sedation with a given treatment is, in fact, important to know when assessing the potential … It is precisely because of the rare events in relation to sedation that we have been unable to come

63. Management of Insomnia Disorder in Adults: Current State of the Evidence (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - people with primary depression �� Severe anaphylactic or anaphylactoid reactions �� Possible profound sedation

64. Evidence Report on the (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
    June 15, 2010 - Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation

65. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … THC to CBD ratio) may be associated with moderate improvement in pain severity and increased risk of sedation … Sedation for comparable THC to CBD ratio versus placebo (short-term, 4 weeks to 6 months followup) … Sedation for high THC versus placebo (short-term, 4 weeks to 6 months followup) Abbreviations: CI … Placebo Sedation 3 RCTs (N=335)9- 11 Moderate Direct Consistent Imprecise Unknown Moderate effect

66. Disposition of Comments Report for Acute Migraine Treatment in Emergency Settings (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
    November 27, 2012 - Commentator & Affiliation Section Comment Response Peer Reviewer #4 Structured abstract "The risk of sedation … the following information from the abstract for both metoclopromide and neuroleptics: "The risk of sedation … The risk of sedation is from the side effects section under both agents, and the reference to the 10 … The most common side effects were skin and local reactions, sedation, digestive problems, nausea or … reestablish the homeostasis needed to abort an attack. no one has looked to low dose ketamine followed by sedation

67. Disposition of Comments Report for Comparative Effectiveness Review #68 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
    July 01, 2012 - Peer Reviewer 3 Introduction I recommend adding that NPPV does not require moderate sedation (instead … of only “deep” sedation) Page ES-2, line 26: add “moderate and/or” just prior to “…deep sedation” … Page 3, line 39: add “moderate and/or” just prior to “…deep sedation” The text has been modified to … specify “moderate and/or deep sedation.”

68. Ptsd-Adults-Trauma-Interventions Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_executive.pdf
    April 01, 2013 - In one RCT, dosing of sedation (light vs. deep) in critically ill patients did not affect posttraumatic … Robbery victims29 PTSD symptom severity Inconclusive, single trial (N=77) Insufficient Pharmacological sedation … trial (N=236), inconsistent findings at different assessment intervals Insufficient Pharmacological sedation … One randomized open-label trial considered comparative risk of harms from light versus deep sedation … Randomized trial of light versus deep sedation on mental health after critical illness.

69. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

70. Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/wireless-motility-capsule/research-protocol
    December 01, 2019 - testing procedure, a manometry catheter is inserted into the pyloric channel with endoscopic guidance and sedation … motility capsule include that it is wireless and painless, can be used in an office setting without sedation … The catheter is left in place in some cases for up to 24 hours, and recordings are obtained after sedation … would capture the number of hours without anything by mouth before the procedure and the method of sedation

71. Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorder | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/autism-update/clinician
    December 01, 2019 - insufficient] Harms Aripiprazole and risperidone are associated with significant weight gain, sedation

72. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/acs-depression/research-protocol
    June 01, 2021 - Other risks: akathisia, restlessness, sedation, headache, nausea and vomiting Olanzapine 6 … safety alert: DRESS (drug reaction with eosinophilia and systemic symptoms) FDA black box: delirium/sedation … syndrome with long acting injection (likely not relevant to use in depression) Other risks: akathisia, sedation … Quetiapine 7 Yes, as an adjunct with an antidepressant Other risks: sedation, hypertension, cataracts … but not limited to constipation, urinary retention and blurred vision) and CNS depression including sedation

73. Layout 1 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
    January 01, 2007 - In the CATIE trial, risperidone, quetiapine, and olanzapine were each more likely to cause sedation than … Odds were also higher for gastrointestinal problems, increased salivation, fatigue, EPS, and sedation … Compared to placebo, all atypicals were associated with sedation in multiple pooled analyses for all

74. Comparative Effectiveness of First and Second Generation Antipsychotics in the Pediatric and Young Adult Populations | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children/research-protocol
    December 01, 2019 - Side effects vary among the various medications, but common side effects include dry mouth, sedation, … effects Weight gain (e.g., using Body Mass Index (BMI) growth charts) Agitation Constipation Sedation … events: extrapyramidal effects, weight gain (e.g., using BMI growth charts), agitation, constipation, sedation

75. Cannabis-2023-Surv-Rep-1-App-F (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

76. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

77. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

78. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
    March 14, 2012 - procedure, a manometry catheter is inserted into the pyloric channel with endoscopic guidance and sedation … motility capsule include that it is wireless and painless, can be used in an office setting without sedation … The catheter is left in place in some cases for up to 24 hours, and recordings are obtained after sedation … would capture the number of hours without anything by mouth before the procedure and the method of sedation

79. Amended Protocol: Interventions for Breathlessness in Patients with Advanced Cancer (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
    May 19, 2020 - rate • Blood pressure • Objective measure of exercise capacity, e.g., 6-minute walk test • Level of sedation … bicarbonate levels • Heart rate • Blood pressure • Objective measure of exercise capacity • Level of sedation

80. Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
    March 01, 2020 - that atypical antipsychotics can increase chances of adverse events such as significant weight gain, sedation … Neurological Cerebrovascular accident (CVA) Akathisia Extrapyramidal Symptoms Tardive Dyskinesia Sedation